Leukoencephalopathy due to heroin inhalation (chasing the dragon) - UpToDate https://www-uptodate-com.m-hupa.a17.csinet.es/contents/leukoencephalopathy-due-to-heroin-inhalation-...

Official reprint from UpToDate®

www.uptodate.com ©2020 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Leukoencephalopathy due to heroin inhalation (chasing the dragon)

Author: Amy T Waldman, MD
Section Editor: Francisco González-Scarano, MD
Deputy Editor: John F Dashe, MD, PhD

All topics are updated as new evidence becomes available and our peer review process is complete.

Literature review current through: Apr 2020. | This topic last updated: Sep 19, 2018.

INTRODUCTION

Although heroin use by inhalation ("chasing the dragon") can be traced back to the 1950s [1], the leukoencephalopathy and neurologic symptoms
associated with this method of heroin abuse were initially described in 1982 in a report from the Netherlands [2].

This topic will discuss the pathogenesis, clinical features, diagnosis, and management of heroin leukoencephalopathy from chasing the dragon.

TERMINOLOGY AND DESCRIPTION

"Chasing the dragon" is a method of heroin vapor inhalation that is distinct from smoking or sniffing heroin [1,3]. Other names for this process
include "chinesing" and "Chinese blowing." A small amount of heroin powder is placed on aluminum foil, which is then heated by placing a match or
lighter underneath. The white powder becomes a reddish-brown gelatinous substance that releases a thick, white smoke, which resembles a
dragon's tail. The fumes are "chased" or inhaled through a straw or small tube [4].

PATHOGENESIS

Heroin and its metabolite, 6-monoacetylmorphine (6-MAM), are hydrolyzed to morphine, which is then conjugated to morphine-3-glucuronide and
morphine-6-glucuronide. Plasma levels of heroin and its metabolites are detected after inhalation [5], and morphine and morphine-3-glucuronide are
detectable in cerebrospinal fluid (CSF) after chronic systemic use [6]. Heroin and its metabolites cross the blood-brain barrier; however, the
mechanism of neurologic injury related to heroin inhalation is unknown.

Since heroin leukoencephalopathy is observed infrequently among users who inject or snort heroin [7], it is possible that unknown toxins contained
in the heroin pyrolysate (the product of chemical change caused by heating) are responsible for the condition [3]. However, the neuropathology was
not replicated in rats exposed to this compound [2]. Triethyl tin (TET), a component of inorganic tin, was also suspected since TET poisoning results
in vacuolar white matter edema [3,8], but an etiologic role for TET is unlikely, since the TET content in aluminum foil is negligible [3].

Aluminum toxicity has also been suspected as the etiology. However, when patients on dialysis were exposed to a contaminated water supply, the
neurologic symptoms of aluminum toxicity differed from heroin leukoencephalopathy. Affected individuals presented with mental status changes and
seizures, progressing, in some, to death [9]. An earlier pathology report of a fatal encephalopathy in dialysis patients linked the syndrome to
aluminum accumulation in brain gray matter (unlike the white matter pathology seen in leukoencephalopathy) [10]. (See "Aluminum toxicity in
chronic kidney disease", section on 'Acute encephalopathy'.)

Mitochondrial dysfunction may play a role in the development of heroin leukoencephalopathy, as suggested by mitochondrial changes in specimens
from brain biopsy [2], by elevated lactate on magnetic resonance spectroscopy [3], and by the clinical improvement associated with antioxidant
therapy that has been reported in a few patients [3]. (See 'Treatment' below.)

In this syndrome, parkinsonian symptoms may be caused by reversible inhibition of tetrahydrobiopterin metabolism; tetrahydrobiopterin is required
for the conversion of tyrosine to levodopa, the precursor of dopamine, and for the conversion of tryptophan to serotonin [11].

EPIDEMIOLOGY

Despite the prevalence of heroin abuse, only 160 cases of leukoencephalopathy due to heroin inhalation (chasing the dragon) had been reported by
the year 2018 [7]. However, inhaled heroin use may be on the rise.

1 de 9 20/05/2020 1:47
Leukoencephalopathy due to heroin inhalation (chasing the dragon) - UpToDate https://www-uptodate-com.m-hupa.a17.csinet.es/contents/leukoencephalopathy-due-to-heroin-inhalation-...

CLINICAL FEATURES

Heroin inhalation leukoencephalopathy has a variable clinical spectrum associated with a spongiform leukoencephalopathy.

Presentation and course — A 2018 review of the literature of patients with confirmed acute heroin inhalation leukoencephalopathy identified 88
cases [7] that were divided into three levels of clinical severity (mild, moderate, or severe [12]):

● A mild syndrome, characterized by inattentiveness, confusion, ataxia, and psychomotor symptoms, in 21 percent

● A moderate syndrome, characterized by corticospinal or extrapyramidal involvement and severe confusion or delirium, in 52 percent

● A severe syndrome, characterized by generalized motor impairment, apathy/abulia without language disorders or apraxia, and impaired
alertness, in 27 percent; death ensued in two-thirds of these cases (see 'Prognosis' below)

In the initial cohort of 47 heroin vapor inhalers from the Netherlands, the leukoencephalopathy occurred in three stages [2]. In the first stage, the
initial symptoms (in order of decreasing frequency) were:

● Soft/pseudobulbar speech
● Cerebellar ataxia
● Motor restlessness
● Apathy/abulia/bradyphrenia

After two to four weeks, approximately half of the patients progressed to the second (intermediate) stage, which was characterized by rapid
worsening of cerebellar symptoms and additional features [2]:

● Pyramidal tract signs

● Hyperactive reflexes
● Spastic hemiplegia or quadriplegia
● Tremor and myoclonus
● Chorea and athetosis

A few weeks later, one-fourth of the initial cohort entered the terminal stage and developed the following symptoms before death ensued [2]:

● "Stretching spasms"
● Hypotonic/areflexic paresis
● Akinetic mutism
● Central pyrexia

Various features of parkinsonism, in some cases reversible, may be seen as early or late manifestations of heroin leukoencephalopathy [2,3,11].
These include bradykinesia, tremor, chorea, short festinating steps, masked facies, soft speech, cogwheel rigidity, and loss of postural reflexes.

Communicating and obstructive hydrocephalus, requiring neurosurgical intervention, have been described as complications of heroin inhalation in
case reports [13,14].

Once symptoms develop, progression of disease can continue for a few weeks up to six months in the absence of continued exposure [2,3,15], a
phenomenon called "coasting" [16].

Neuroimaging — Brain MRI (image 1) shows diffuse, symmetrical white matter hyperintensities on T2 and fluid-attenuated inversion recovery
(FLAIR) sequences in the cerebellum, posterior cerebrum, and posterior limbs of the internal capsule. There can be additional signal abnormalities
in the splenium of the corpus callosum, the corticospinal tracts, the lemniscal pathway in the brainstem, and the hippocampus [3,17-20]. Increased
signal in periventricular white matter may be present on diffusion-weighted images with corresponding low signal on apparent diffusion coefficient
(ADC) maps [21], perhaps due to vacuolization rather than infarction. Most patients demonstrate T2 shine-through with increased ADC signal [22].

A posterior-anterior gradient is typically seen in the supratentorial white matter, and the frontal lobes are therefore relatively spared [3]. However,
with significant heroin abuse, there may be frontal lobe involvement.

Magnetic resonance spectroscopy abnormalities in three patients with heroin leukoencephalopathy included abnormally elevated lactate suggesting
mitochondrial dysfunction in the affected white matter and decreased levels of N-acetyl aspartate and choline in the white matter, gray matter, and
cerebellum [3,20].

Laboratory — Electroencephalography in two severely affected patients showed moderate diffuse slowing with excess delta, consistent with a

2 de 9 20/05/2020 1:47
Leukoencephalopathy due to heroin inhalation (chasing the dragon) - UpToDate https://www-uptodate-com.m-hupa.a17.csinet.es/contents/leukoencephalopathy-due-to-heroin-inhalation-...

global encephalopathy [3].

Neuropathology — Pathologic data from autopsy cases as well as brain biopsies reveal spongiform degeneration of white matter with relative
sparing of subcortical U-fibers, and vacuole formation in oligodendroglia and myelin sheaths visible with electron microscopy. Axons are typically
spared, and demyelination is not a prominent feature. The deep white matter is edematous, but inflammation is absent. Mitochondria are also
abnormal [3].

DIAGNOSIS

The diagnosis of heroin inhalation leukoencephalopathy is clinical and should be suspected in patients with a history of chasing the dragon who
present with acute or subacute onset of neurologic abnormalities. These may include one or more of the following features [2,3,17]:

● Cerebellar, pyramidal, or extrapyramidal signs

● Neurobehavioral changes, including confusion, apathy/abulia, or motor restlessness

The diagnosis is supported by the characteristic neuroimaging findings (see 'Neuroimaging' above). A positive urine test for morphine is supportive
of heroin use in the preceding 48 to 96 hours. The presence of the metabolite 6-monoacetylmorphine (6-MAM) is specific for heroin. However,
6-MAM is detectable for only two to eight hours after heroin use. Therefore, the absence of 6-MAM in urine that is positive for opioids does not rule
out the use of heroin [7].

Diagnostic uncertainty is increased when the method of heroin abuse or history of exposure is unknown.

Proposed diagnostic criteria for heroin leukoencephalopathy due to inhalation (chasing the dragon) consist of the following [7]:

● Inclusion criteria:

• 1) Presence of a clinical syndrome suggestive of leukoencephalopathy

• 2) Positive heroin toxicology testing

• 3) Confirmed report of heroin inhalation by the patient, his or her next of kin, or a witness

• 4) Supportive neuroimaging

• 5) Neuropathology findings consistent with spongiform leukoencephalopathy

● Exclusion criteria:

• Confirmed history of acute intoxication or exposure to a toxin other than heroin that is capable of producing a chasing the dragon-like
outcome

• Overt clinical picture suggesting an infectious, demyelinating, vascular, or paraneoplastic cause

• Neuroimaging consistent with predominantly cortical involvement along with sparing of subcortical areas and posterior fossa

The diagnosis of chasing the dragon is considered definite if the patient fulfills all of the inclusion criteria; probable if the patient fulfills inclusion
criteria 1 through 4, and possible if only inclusion criteria 1 through 3 are met, or if criteria 1 through 4 are met but are accompanied by confirmed
polysubstance abuse or heroin abuse by multiple routes [7]. While postmortem neuropathology remains the gold standard for diagnosis, brain
biopsy is discouraged in clinical practice.

DIFFERENTIAL DIAGNOSIS

Heroin addiction has been associated with a number of neurologic conditions [23], including brain abscess [24], transverse myelitis [25,26],
neuropathy [27,28], and rhabdomyolysis with myoglobinuria [26,29,30]. However, these disorders are not likely to be confused with
leukoencephalopathy.

Leukoencephalopathy — In contrast, leukoencephalopathy may occur after global anoxic-ischemic injury or after toxic exposure to a variety of
agents, including the following [12,31]:

● Antineoplastic agents (cranial irradiation, methotrexate, carmustine, cisplatin, cytarabine, fluorouracil, levamisole, fludarabine, thiotepa,
interleukin-2, interferon alfa)

3 de 9 20/05/2020 1:47
Leukoencephalopathy due to heroin inhalation (chasing the dragon) - UpToDate https://www-uptodate-com.m-hupa.a17.csinet.es/contents/leukoencephalopathy-due-to-heroin-inhalation-...

● Immunosuppressive drugs (cyclosporine, tacrolimus)

● Antimicrobial agents (amphotericin B, hexachlorophene)

● Drugs of abuse (toluene, ethanol, cocaine, 3,4-methylenedioxymethamphetamine, intravenous heroin, inhaled heroin pyrolysate, psilocybin,
benzodiazepines)

● Environmental toxins (carbon monoxide, arsenic, carbon tetrachloride)

Anoxic-ischemic injury — Global anoxia or ischemia, which can be precipitated by drug overdose or cardiopulmonary arrest, typically affects the
gray matter in the cerebral cortex and various subcortical structures, such as the globus pallidus, with the cerebellum less frequently involved
[32-34].

Cerebral white matter damage may occur with anoxic-ischemic injury, particularly after prolonged hypoxia and hypotension [33]. The radiologic
appearance of white matter damage may be delayed [34]. Nevertheless, there are reports of early preferential involvement of white matter after
anoxic-ischemic injury [35,36]. In addition, drug overdose from intravenous heroin use has been reported as a cause of anoxic-ischemic
leukoencephalopathy [33].

Drugs of abuse — Varying degrees of white matter injury may be found in chronic abusers of heroin, alcohol, and toluene [12].

● Heroin inhalation by other modalities (ie, sniffing, snorting, or smoking) and intravenous heroin use may cause symmetric, confluent T2 and
fluid-attenuated inversion recovery (FLAIR) hyperintense lesions on brain MRI in the frontoparietal white matter (with or without sparing of the U
fibers) and centrum semiovale [37,38]. The brainstem and cerebellum are often spared, distinguishing these abnormalities from the imaging
characteristics in chasing the dragon.

● Chronic alcohol abuse is associated with white matter damage. Alcohol abusers, including those with liver disease and Wernicke
encephalopathy, lose a disproportionate amount of subcortical white matter compared with cortical gray matter. Marchiafava-Bignami disease is
a rare disorder of demyelination or necrosis of the corpus callosum and adjacent subcortical white matter that occurs predominantly in
malnourished alcoholics. (See "Overview of the chronic neurologic complications of alcohol", section on 'Marchiafava-Bignami disease'.)

● Chronic toluene abuse from inhalation of vapor in glue ("glue sniffing"), paint, and paint thinner is associated with neurologic impairment,
including dementia and selective white matter injury [39]. Widespread white matter hyperintensity is seen on brain MRI in severely affected
patients with toluene leukoencephalopathy. (See "Inhalant abuse in children and adolescents".)

A case report described a severe diffuse leukoencephalopathy that followed methylenedioxymethamphetamine (MDMA, also called ecstasy) use
and respiratory insufficiency [40]. However, the relative contribution of anoxic-ischemic injury compared with the leukoencephalopathy is unclear.

TREATMENT

There is no proven treatment for heroin leukoencephalopathy.

Empiric antioxidant therapy (with either coenzyme Q10 [300 mg four times a day] alone, or coenzyme Q10 in combination with vitamin E [2000 mg
daily] and vitamin C [2000 mg daily]) has been used to treat nine patients with heroin inhalation leukoencephalopathy [3,17,41-44], with varying
improvement in five and deterioration or no change in four [3,45].

Given these data, the absence of proven treatment, and the low likelihood of serious side effects, we suggest antioxidant therapy with the
combination of coenzyme Q10, vitamin C, and vitamin E for patients with heroin leukoencephalopathy.

PROGNOSIS

The severity of disease probably depends on the duration and cumulative amount of heroin inhaled, as well as presence of comorbidities, including
other substance abuse.

In the 2018 systematic review of heroin inhalation, with outcome data for 83 cases, 17 patients (20 percent) died; details of the cause of death were
often unreported [7]. Nearly all the deaths occurred among the 24 patients with severe symptoms, where 16 (67 percent) died. Among 42 patients
with moderate symptoms, only one patient (2 percent) died. There were no deaths among the 17 patients with mild symptoms.

Patients who survive often require physical and drug rehabilitation.

4 de 9 20/05/2020 1:47
Leukoencephalopathy due to heroin inhalation (chasing the dragon) - UpToDate https://www-uptodate-com.m-hupa.a17.csinet.es/contents/leukoencephalopathy-due-to-heroin-inhalation-...

SUMMARY AND RECOMMENDATIONS

● "Chasing the dragon" is a method of heroin vapor inhalation that is distinct from smoking or sniffing heroin and is associated with
leukoencephalopathy. (See 'Terminology and description' above.)

● The mechanism of neurologic injury related to heroin inhalation is unknown; toxins contained in the heroin pyrolysate may be responsible for
the condition. (See 'Pathogenesis' above.)

● Initial symptoms of heroin leukoencephalopathy include soft speech, ataxia, motor restlessness, bradyphrenia, and apathy/abulia. Some
patients develop progressive disease with later occurrence of pyramidal signs, hyperactive reflexes, pseudobulbar palsy, spastic paresis,
tremor, myoclonus, chorea, and athetosis. Severe disease is characterized by fever, akinetic mutism, spasms, hypotonia, areflexia, and death.
(See 'Clinical features' above.)

● Brain MRI (image 1) shows diffuse, symmetrical white matter hyperintensities on T2 and fluid-attenuated inversion recovery (FLAIR) sequences
with a posterior to anterior gradient of involvement; the frontal lobes are therefore relatively spared. (See 'Neuroimaging' above.)

● Neuropathology reveals spongiform degeneration with relative sparing of subcortical U-fibers; demyelination is not a prominent feature. (See
'Neuropathology' above.)

● The diagnosis of heroin inhalation leukoencephalopathy is clinical, and is supported by the characteristic neuroimaging findings. The differential
diagnosis includes leukoencephalopathy following global anoxic-ischemic injury or exposure to other drugs of abuse. (See 'Diagnosis' above.)

● Although there is no proven treatment for heroin leukoencephalopathy, we suggest antioxidant therapy (Grade 2C). The suggested regimen is
coenzyme Q10 (300 mg four times a day), vitamin E (2000 mg daily), and vitamin C (2000 mg daily). (See 'Treatment' above.)

ACKNOWLEDGMENT

The editorial staff at UpToDate would like to acknowledge Alan Percy, MD, who contributed to earlier versions of this topic review.

Use of UpToDate is subject to the Subscription and License Agreement.

REFERENCES

1. Strang J, Griffiths P, Gossop M. Heroin smoking by 'chasing the dragon': origins and history. Addiction 1997; 92:673.

2. Wolters EC, van Wijngaarden GK, Stam FC, et al. Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet 1982; 2:1233.

3. Kriegstein AR, Shungu DC, Millar WS, et al. Leukoencephalopathy and raised brain lactate from heroin vapor inhalation ("chasing the
dragon"). Neurology 1999; 53:1765.

4. Keogh CF, Andrews GT, Spacey SD, et al. Neuroimaging features of heroin inhalation toxicity: "chasing the dragon". AJR Am J Roentgenol
2003; 180:847.

5. Rook EJ, van Ree JM, van den Brink W, et al. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin,
by intravenous or by inhalation route in opioid-dependent patients. Basic Clin Pharmacol Toxicol 2006; 98:86.

6. Smith MT. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol
Physiol 2000; 27:524.

7. Alambyan V, Pace J, Miller B, et al. The Emerging Role of Inhaled Heroin in the Opioid Epidemic: A Review. JAMA Neurol 2018; 75:1423.

8. Squibb RE, Carmichael NG, Tilson HA. Behavioral and neuromorphological effects of triethyl tin bromide in adult rats. Toxicol Appl Pharmacol
1980; 55:188.

9. Berend K, van der Voet G, Boer WH. Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe.
Kidney Int 2001; 59:746.

5 de 9 20/05/2020 1:47
Leukoencephalopathy due to heroin inhalation (chasing the dragon) - UpToDate https://www-uptodate-com.m-hupa.a17.csinet.es/contents/leukoencephalopathy-due-to-heroin-inhalation-...

10. Alfrey AC, LeGendre GR, Kaehny WD. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 1976; 294:184.

11. Heales S, Crawley F, Rudge P. Reversible parkinsonism following heroin pyrolysate inhalation is associated with tetrahydrobiopterin deficiency.
Mov Disord 2004; 19:1248.

12. Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med 2001; 345:425.

13. Bui DH, Pace J, Manjila S, et al. Heroin inhalation complicated by refractory hydrocephalus: A novel presentation. Neurology 2015; 84:2093.

14. Dastur CK, Chang GY. Heroin inhalation complicated by refractory hydrocephalus: A novel presentation. Neurology 2015; 85:2083.

15. Sempere AP, Posada I, Ramo C, Cabello A. Spongiform leucoencephalopathy after inhaling heroin. Lancet 1991; 338:320.

16. Berger AR, Schaumburg HH, Schroeder C, et al. Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a
prospective study of pyridoxine neurotoxicity. Neurology 1992; 42:1367.

17. Long H, Deore K, Hoffman RS, Nelson LS. A fatal case of spongiform leukoencephalopathy linked to "chasing the dragon". J Toxicol Clin
Toxicol 2003; 41:887.

18. Weber W, Henkes H, Möller P, et al. Toxic spongiform leucoencephalopathy after inhaling heroin vapour. Eur Radiol 1998; 8:749.

19. Gupta PK, Krishnan PR, Sudhakar PJ. Hippocampal involvement due to heroin inhalation--"chasing the dragon". Clin Neurol Neurosurg 2009;
111:278.

20. Offiah C, Hall E. Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and MR spectroscopy. Clin
Radiol 2008; 63:146.

21. McKinney AM, Kieffer SA, Paylor RT, et al. Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-
weighted and FLAIR imaging. AJR Am J Roentgenol 2009; 193:192.

22. Hagel J, Andrews G, Vertinsky T, et al. "Chasing the dragon"--imaging of heroin inhalation leukoencephalopathy. Can Assoc Radiol J 2005;
56:199.

23. Hill MD, Cooper PW, Perry JR. Chasing the dragon--neurological toxicity associated with inhalation of heroin vapour: case report. CMAJ 2000;
162:236.

24. Hershewe GL, Davis LE, Bicknell JM. Primary cerebellar brain abscess from nocardiosis in a heroin addict. Neurology 1988; 38:1655.

25. Richter RW, Rosenberg RN. Transverse myelitis associated with heroin addiction. JAMA 1968; 206:1255.

26. Sahni V, Garg D, Garg S, et al. Unusual complications of heroin abuse: transverse myelitis, rhabdomyolysis, compartment syndrome, and
ARF. Clin Toxicol (Phila) 2008; 46:153.

27. Amnueilaph R, Boongird P, Leechawengwongs M, Vejjajiva A. Heroin neuropathy. Lancet 1973; 1:1517.

28. Loizou LA, Boddie HG. Polyradiculoneuropathy associated with heroin abuse. J Neurol Neurosurg Psychiatry 1978; 41:855.

29. Schreiber SN, Liebowitz MR, Bernstein LH, Srinivasan K. Limb compression and renal impairment (crush syndrome) complicating narcotic
overdose. N Engl J Med 1971; 284:368.

30. de Gans J, Stam J, van Wijngaarden GK. Rhabdomyolysis and concomitant neurological lesions after intravenous heroin abuse. J Neurol
Neurosurg Psychiatry 1985; 48:1057.

31. Aljarallah S, Al-Hussain F. Acute fatal posthypoxic leukoencephalopathy following benzodiazepine overdose: a case report and review of the
literature. BMC Neurol 2015; 15:69.

32. Meyer A. Intoxication. In: Greenfield's Neuropathology, Blackwood W, McMenemey WH, Meyer A, et al (Eds), Williams & Wilkins, Baltimore 19
67.

33. Ginsberg MD, Hedley-Whyte ET, Richardson EP Jr. Hypoxic-ischemic leukoencephalopathy in man. Arch Neurol 1976; 33:5.

34. Sawada H, Udaka F, Seriu N, et al. MRI demonstration of cortical laminar necrosis and delayed white matter injury in anoxic encephalopathy.

6 de 9 20/05/2020 1:47
Leukoencephalopathy due to heroin inhalation (chasing the dragon) - UpToDate https://www-uptodate-com.m-hupa.a17.csinet.es/contents/leukoencephalopathy-due-to-heroin-inhalation-...

Neuroradiology 1990; 32:319.

35. Chalela JA, Wolf RL, Maldjian JA, Kasner SE. MRI identification of early white matter injury in anoxic-ischemic encephalopathy. Neurology
2001; 56:481.

36. Molloy S, Soh C, Williams TL. Reversible delayed posthypoxic leukoencephalopathy. AJNR Am J Neuroradiol 2006; 27:1763.

37. Blasel S, Hattingen E, Adelmann M, et al. Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR imaging and
clinical features in three patients. Clin Neuroradiol 2010; 20:48.

38. Lefaucheur R, Lebas A, Gérardin E, et al. Leucoencephalopathy following abuse of sniffed heroin. J Clin Neurosci 2017; 35:70.

39. Filley CM, Halliday W, Kleinschmidt-DeMasters BK. The effects of toluene on the central nervous system. J Neuropathol Exp Neurol 2004;
63:1.

40. Bertram M, Egelhoff T, Schwarz S, Schwab S. Toxic leukencephalopathy following "ecstasy" ingestion. J Neurol 1999; 246:617.

41. Gacouin A, Lavoue S, Signouret T, et al. Reversible spongiform leucoencephalopathy after inhalation of heated heroin. Intensive Care Med
2003; 29:1012.

42. Jee RC, Tsao WL, Shyu WC, et al. Heroin vapor inhalation-induced spongiform leukoencephalopathy. J Formos Med Assoc 2009; 108:518.

43. Cordova JP, Balan S, Romero J, et al. 'Chasing the dragon': new knowledge for an old practice. Am J Ther 2014; 21:52.

44. Bartlett E, Mikulis DJ. Chasing "chasing the dragon" with MRI: leukoencephalopathy in drug abuse. Br J Radiol 2005; 78:997.

45. Kriegstein AR, Armitage BA, Kim PY. Heroin inhalation and progressive spongiform leukoencephalopathy. N Engl J Med 1997; 336:589.

Topic 1696 Version 15.0

7 de 9 20/05/2020 1:47
Leukoencephalopathy due to heroin inhalation (chasing the dragon) - UpToDate https://www-uptodate-com.m-hupa.a17.csinet.es/contents/leukoencephalopathy-due-to-heroin-inhalation-...

GRAPHICS

MRI of severe heroin-induced leukoencephalopathy

Axial T2-weighted magnetic resonance images of a severe case of heroin-induced leukoencephalopathy (A through C): In the
medulla, signal abnormality is present in the regions of the pyramidal tracts, medial lemnisci, and the nucleus tractus solitaries
posteriorly. The white matter of the cerebellar hemispheres is affected symmetrically with relative preservation of the grey
matter of the dentate nuclei. Symmetrical signal abnormality extends throughout the supratentorial deep white matter
including the posterior limbs of the internal capsules. Note preservation of the basal ganglia and thalami in this case. White
matter change extends into the centrum semiovale and subcortical white matter bilaterally including that in the precentral and
postcentral gyri (premotor area, primary motor area, and somatic sensory area).

MRI: magnetic resonance imaging.

Reproduced from: Offiah C, Hall E. Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and
MR spectroscopy. Clin Radiol 2008; 63:146. Illustration used with the permission of Elsevier Inc. All rights reserved.

Graphic 103815 Version 2.0

8 de 9 20/05/2020 1:47
Leukoencephalopathy due to heroin inhalation (chasing the dragon) - UpToDate https://www-uptodate-com.m-hupa.a17.csinet.es/contents/leukoencephalopathy-due-to-heroin-inhalation-...

Contributor Disclosures
Amy T Waldman, MD Grant/Research/Clinical Trial Support: Ionis Pharmaceuticals [Alexander Disease (Observational study)]; Retrophin [Cerebrotendinous
xanthomatosis (Observational study)]. Francisco González-Scarano, MD Equity Ownership/Stock Options: Multiple, but traded by advisors without personal input
[Pharmaceutical]. Patent Holder: La Crosse [Monoclonal antibodies]. Consultant/Advisory Boards: DeLoitte [Physician Leadership Academy]. John F Dashe, MD,
PhD Nothing to disclose

Contributor disclosures are reviewed for conflicts of interest by the editorial group. When found, these are addressed by vetting through a multi-level review process,
and through requirements for references to be provided to support the content. Appropriately referenced content is required of all authors and must conform to
UpToDate standards of evidence.

Conflict of interest policy

9 de 9 20/05/2020 1:47